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A novel phosphatase cascade regulates
differentiation in Trypanosoma brucei
via a glycosomal signaling pathway
Bala´zs Szo¨}or,1,4 Irene Ruberto,1 Richard Burchmore,2 and Keith R. Matthews1,3
1Centre for Immunity, Infection, and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences,
University of Edinburgh, Edinburgh EH9 3JT; United Kingdom; 2Sir Henry Wellcome Proteomics Facility, University of Glasgow
G12 8QQ, United Kingdom
In the mammalian bloodstream, the sleeping sickness parasite Trypanosoma brucei is held poised for trans-
mission by the activity of a tyrosine phosphatase, TbPTP1. This prevents differentiation of the transmissible
‘‘stumpy forms’’ until entry into the tsetse fly, whereupon TbPTP1 is inactivated and major changes in parasite
physiology are initiated to allow colonization of the arthropod vector. Using a substrate-trapping approach, we
identified the downstream step in this developmental signaling pathway as a DxDxT phosphatase, TbPIP39,
which is activated upon tyrosine phosphorylation, and hence is negatively regulated by TbPTP1. In vitro, TbPIP39
promotes the activity of TbPTP1, thereby reinforcing its own repression, this being alleviated by the trypanosome
differentiation triggers citrate and cis-aconitate, generating a potentially bistable regulatory switch. Supporting
a role in signal transduction, TbPIP39 becomes rapidly tyrosine-phosphorylated during differentiation, and RNAi-
mediated transcript ablation in stumpy forms inhibits parasite development. Interestingly, TbPIP39 localizes in
glycosomes, peroxisome-like organelles that compartmentalize the trypanosome glycolytic reactions among other
enzymatic activities. Our results invoke a phosphatase signaling cascade in which the developmental signal is
trafficked to a unique metabolic organelle in the parasite: the glycosome. This is the first characterized
environmental signaling pathway targeted directly to a peroxisome-like organelle in any eukaryotic cell.
[Keywords: Glycosome; peroxisome; signal transduction; phosphatase; Trypanosoma brucei; differentiation]
Supplemental material is available at http://www.genesdev.org.
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Developmental events in eukaryotic cells are often driven
by a transmembrane signaling event, this being trans-
duced via phosphorylation/dephosphorylation of signal-
ing proteins to generate a cellular response. Such signaling
events are particularly important in unicellular eukary-
otes, which are required to react to external stimuli, either
as part of an adaptive response to a changing environment,
or through triggered developmental responses intrinsic to
their normal life cycle progression. An excellentmodel for
such developmentally regulated responses is the African
trypanosome,Trypanosoma brucei (Fenn and Matthews
2007). These are important disease organisms of sub-
Saharan Africa, where they generate significant problems
for public health and economic welfare (Barrett et al.
2003). Furthermore, as highly diverged and evolutionarily
ancient organisms (Sogin et al. 1986), they have provided
an important paradigm for organelle evolution and func-
tion in the eukaryotic cell (Hannaert et al. 2003; He et al.
2004, 2005; Broadhead et al. 2006; He 2007), exemplified
by their use of extensive RNA editing for mitochon-
drial transcripts (Stuart et al. 2005), and by their posses-
sion of unusual peroxisome-like organelles, glycosomes
(Opperdoes 1987). These compartmentalize the trypano-
some glycolytic enzymes, which in other eukaryotes are
cytosolic, thereby avoiding the lethal consequences of the
‘‘turbo design’’ of glycolysis (Teusink et al. 1998; Bakker
et al. 2000). Glycosomes also contain enzymes required
for ether lipid biosynthesis, the b oxidation of fatty acids,
as well as several additional activities (Michels et al.
2006; Opperdoes and Szikora 2006), although their pre-
cise enzymatic composition and number is regulated dur-
ing the trypanosome life cycle (Michels et al. 2006).
The life cycle regulation of organellar function is a
central component of the developmental biology of the
trypanosome, which entails extensive cellular remodel-
ing during passage from themammalian blood to themid-
gut of the tsetse fly, the parasite’s vector (Matthews 2005).
These differentiation events are triggered by exposure
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of bloodstream parasites to citrate/cis-aconitate (CCA)
(Czichos et al. 1986; Engstler and Boshart 2004). This
signal is transduced via a family of surface transporters,
PAD proteins (Dean et al. 2009), with signal recognition
being promoted by temperature reduction to 20°C—
conditions encountered upon uptake by feeding tsetse
flies (Engstler and Boshart 2004). PAD proteins are
expressed on the cell surface of stumpy forms, the stage
of the bloodstream parasite population adapted for trans-
mission to tsetse flies. Importantly, stumpy forms are
held ready for this developmental change by the action of
a tyrosine phosphatase, TbPTP1 (Szo¨}or et al. 2006), until
differentiation is triggered. Thus, the activity of TbPTP1
prevents stumpy forms from initiating differentiation
and, when this enzyme is inactivated after exposure to
either CCA or chemical inhibitors of PTPs, the cells dif-
ferentiate from bloodstream to procyclic forms (Szo¨}or
et al. 2006). This places TbPTP1 at the head of an intra-
cellular signaling pathway whose components are com-
pletely unknown.
Here we exploited a tyrosine phosphatase substrate
selection strategy to identify the downstream step in the
differentiation signaling pathway. This has identified a
glycosomally targeted DxDxT family Ser/Thr phospha-
tase, invoking the presence of a phosphatase signaling
cascade directing developmental regulation in trypano-
somes. Our findings provide the first evidence of de-
velopmentally regulated signal transduction via the gly-
cosome, and link the external differentiation stimulus
through this signaling pathway to control of the trypano-
some life cycle.
Results
TbPTP1 substrate is a novel DxDxT
phosphatase, TbPIP39
To identify potential substrates of TbPTP1, we exploited
the ability to generate mutant PTP enzymes, which bind
but do not release substrates (Blanchetot et al. 2005).
Specifically, His-tagged TbPTP1 was generated in which
residue 199, the catalytic aspartic acid in the predicted
WPD loop (Szo¨}or et al. 2006), was mutated to alanine.
This ‘‘substrate-trapping’’ mutant (TbPTP1-D199A) was
bound to a His trap chelating column, and was used to
select interacting proteins and substrates of TbPTP1 from
stumpy cell lysates. Mass spectrometry reproducibly
identified a selected protein encoded by a gene on chro-
mosome 9, Tb09.160.4460, this being almost identical
(339 out of 343 amino acids) to that encoded by its im-
mediately downstream gene (Tb09.160.4480), invoking
a gene duplication event.Tb09.160.4460 encodes a protein
with a predicted molecular mass of 39 kDa, this being
named TbPIP39 (TbPTP1-interacting protein, 39 kDa).
The TbPIP39 gene is well conserved in those kinetoplas-
tids that have been subject to genome sequence analysis,
although in Trypanosoma cruzi, Trypanosoma vivax, and
Leishmania major, it has not undergone gene duplication
(Supplemental Fig. 1).
To confirm the interaction between TbPTP1 and
TbPIP39, an antibody was raised to TbPIP39 and used to
probe the eluate from stumpy cell lysates incubated with
either His-tagged TbPTP1D199A or wild-type TbPTP1.
Figure 1A demonstrates that the binding of TbPIP39 to
the substrate-trapping TbPTP-D199A was much more
effective than to the wild-type protein (Fig. 1A, lanes 2,3).
To validate this interaction in vivo, transgenic blood-
stream forms were generated ectopically expressing wild-
type TbPTP1 or TbPTP1-D199A proteins, each with a
C-terminal Ty1 epitope tag (Bastin et al. 1996). Since
TbPIP39 expression is induced during differentiation (see
later), cells were treated with cis-aconitate for 24 h,
and Ty1-specific antibody was used to immunoprecipi-
tate TbPTP1. This revealed coimmunoprecipitation of
TbPIP39 with the TbPTP-D199A substrate-trapping mu-
tant, selection being blocked in the presence of a synthetic
peptide comprising the Ty1 epitope (Fig. 1B, cf. lanes 3
and 5). Matching the in vitro pull-down assay, TbPIP39
was selected less efficiently with wild-type TbPTP1 (Fig.
1B, cf. lanes 5 and 10), supportive of the interaction being
stabilized by the substrate-trapping mutation. Confirming
Figure 1. TbPTP1 interacts with TbPIP39 in vitro and in vivo.
(A) Substrate-trapping selection of TbPIP39 by TbPTP1. Wild-
type (WT) or substrate-trapping recombinant TbPTP1 (D199A)
was expressed as a His-tagged fusion protein and then bound to
a His trap chelating column. Lysate from 5 3 108 stumpy cells
was then passed over the column in order to select interacting
proteins. Bound material was eluted from the beads and reacted
with either antibody specific for the His tag (detecting the
TbPTP1 ligand), or TbPIP39. TbPIP39 was preferentially se-
lected by the D199A TbPTP1 substrate-trapping mutant. (B)
Wild-type or D199A TbPTP1-Ty was expressed in cultured
bloodstream form T. brucei, which were then induced to differ-
entiate to procyclic forms for 24 h by the addition of 6 mM cis-
aconitate. Immunoprecipitation was then performed using the
TY-1 epitope-specific antibody, which had been incubated either
with (‘‘blocked beads’’) or without a peptide sequence recog-
nized by the antibody. Input cell lysate, flow-through (ft), or
precipitated material (beads) from each immunoprecipitation,
either with or without blocking, was then reacted with the Ty1-
specific antibody (to detect the ectopically expressed TbPTP1
or D199A TbPTP1) or antibodies detecting TbPIP39 or aldolase
(as a negative control). The D199A-trapping mutant of TbPTP1
preferentially selected TbPIP39, whereas aldolase was not
selected.
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specificity, an unrelated protein, aldolase, was not cose-
lected by immunoprecipitation of the substrate-trapping
or wild-type TbPTP1 (Fig. 1B).
Examination of the sequence of TbPIP39 and its ortho-
logous sequences in related kinetoplastids revealed the
presence of a conserved predicted tyrosine phosphoryla-
tion site (Y278) toward the C terminus (Supplemental
Fig. 1A). Although the trypanosome genome encodes no
tyrosine-specific kinases (Parsons et al. 2005), a group-
based phosphorylation scoring analysis (Xue et al. 2005)
predicted that the Y278 residue could be phosphorylated
effectively in vitro by the human Gardner-Rasheed feline
sarcoma viral (v-fgr) oncogene homolog FGR kinase.
Confirming this, incubating recombinant TbPIP39 with
FGR kinase rapidly generated tyrosine-phosphorylated
TbPIP39 (Fig. 2A, left panel), whereas mutation of Y278
to phenylalanine (Y278F) in TbPIP39 prevented tyrosine
phosphorylation under the same conditions (Fig. 2A, right
panel). Tyrosine-phosphorylated TbPIP39 was then in-
cubated with either wild-type TbPTP1, or a catalytically
dead mutant of TbPTP1 in which the active site cysteine
was mutated to serine (C229S). Figure 2B demonstrates
that TbPIP39 was effectively dephosphorylated by wild-
type TbPTP1, but not by the inactive C229S mutant,
establishing that TbPIP39 not only interacted with sub-
strate-trapping TbPTP1 in cell lysates, but that it could
form a TbPTP1 substrate.
Regulatory interactions between TbPTP1 and TbPIP39
The protein sequence of TbPIP39 suggested that it was
a member of an unusual class of serine/threonine phos-
phatases, with a characteristic DxDx (T/V) motif toward
the N terminus of the predicted catalytic domain (Sup-
plemental Fig. 1A). This family of proteins comprises
FCP1/SCP1, responsible for the dephosphorylation of the
eukaryotic C-terminal domain of RNA polymerase II
(Kamenski et al. 2004), as well as several stress response
phosphatases, typified by the yeast haloacid dehalogenase-
type phosphatases PSR1/PSR2 (Siniossoglou et al. 2000)
and a phosphatase required in nuclear membrane bio-
genesis, Dullard (Kim et al. 2007). The catalytic activity of
this group of phosphatases depends on magnesium ions,
requiring the integrity of the DxDxT motif as the inter-
mediate phosphoryl acceptor (Collet et al. 1998). Con-
sistent with this, the activity of recombinant TbPIP39
against the artificial phosphatase substrate pNPP was
enhanced dramatically (P < 0.001) in the presence of
15 mMMg2+ (Fig. 2C, columns 1,2). Moreover, when res-
idues 55D and 57D were each mutated to glutamic acid
(TbPIP39dEdE), no catalytic activity could be detected
under the same conditions (Fig. 2C, column 3).
To investigate the possibility that the tyrosine phos-
phorylation status of TbPIP39 might modulate its activ-
ity, the activity of TbPIP39 against pNPP was assayed at
time points after incubation with FGR kinase to generate
the tyrosine-phosphorylated form (Fig. 2D). As a control,
the nonphosphorylable TbPIP39 mutant (Y278F) was
incubated under the same conditions. TbPIP39 activity
was progressively enhanced with increasing phosphory-
lation, while the nonphosphorylatable mutant showed no
enhanced activity above its baseline activity. This con-
firmed that the activity of TbPIP39 was enhanced upon
Figure 2. TbPIP39 is a phosphatase with regulatory interaction
with TbPTP1. (A). Recombinant TbPIP39 was incubated with
FGR kinase to generate a tyrosine-phosphorylated form over the
course of 120 min. Tyrosine phosphorylation of the recombinant
protein was detected using the phophotyrosine-specific anti-
body 4G10 (a-pTyr; Millipore). The right panel shows the same
analysis using a mutant form of TbPIP39 in which the predicted
tyrosine phosphorylation site Y278 is mutated to phenylalanine
(F278). In this case, a-pTyr reactivity is lost. (B) Tyrosine-
phosphorylated TbPIP39 is a substrate of TbPTP1. TbPIP39
was incubated with FGR kinase to generate tyrosine-phosphor-
ylated protein, this being detected with the 4G10 antibody
(a-pTyr). Upon incubation with wild-type TbPTP1, tyrosine
phosphorylation of TbPIP39 is lost. In contrast, when incubated
with either buffer alone or a catalytically dead (C229S) TbPTP1
mutant, TbPIP39 remains phosphorylated. (C) Activity against
pNPP of recombinant TbPIP39 in the absence (column 1) or
presence (column 2) of Mg2+. Column 3 shows the same assay as
in column 2, using a dEdE mutant of TbPIP39. Columns 4–7
show the activity against pNPP of TbPTP1 alone (column 4) or
in the presence of 1 mg (column 5), 0.1 mg (column 6), or 0.01 mg
of TbPIP39. No Mg2+ was included in the reactions in columns
4–7, preventing TbPIP39 activity. Statistical analyses used a
general linear model. (*) P < 0.05; (**) P < 0.001. (D) Activity
against pNPP of recombinant TbPIP39 as it becomes tyrosine-
phosphorylated by FGR kinase. With increasing phosphoryla-
tion, the activity increases. (Right graphs) In TbPIP39-Y278F,
no enhanced activity is observed, demonstrating that tyrosine
phosphorylation on Y278 is responsible for TbPIP39 regulation.
The input recombinant proteins are those depicted in A. Sta-
tistical analyses used a general linear model. (*) P < 0.05.
Szo¨}or et al.
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the phosphorylation of Y278, this site being the target of
TbPTP1 activity (Fig. 2B).
As well as TbPTP1 regulating TbPIP39 activity, we also
found evidence that TbPIP39 could reciprocally influence
the activity of TbPTP1. Thus, although 1 mg of TbPIP39
showed negligible activity against pNPP in the absence of
magnesium (Fig. 2C, column 1), when it was incubated
together with 0.1 mg of TbPTP1, the overall activity of the
combined phosphatase enzymes was significantly greater
than the activity of 0.1 mg of TbPTP1 alone (Fig. 2C, cf.
columns 1,4,5). Confirming that this was due to the
activity of TbPTP1, the same analysis using the inactive
D199A mutant of TbPTP1 generated no increase in
phosphatase activity (Supplemental Fig. 2). This demon-
strated that a positive interaction existed between
TbPTP1 and TbPIP39, such that TbPIP39 promoted the
activity of TbPTP1 when in significant molar excess.
In a final assay of the interaction between TbPIP39 and
TbPTP1, we investigated the effect on their respective
phosphatase activities of incubation with citrate, which
acts as a trypanosome differentiation trigger. This was
prompted by the structural analysis of the DxDxT class
phosphatase SCP1, which exhibits a citrate-binding pocket
(Kamenski et al. 2004), the required residues for which are
conserved in TbPIP39 (Supplemental Fig. 1A). Therefore,
we investigated the ability of citrate and the structurally
related differentiation trigger cis-aconitate to moderate
the activity of either TbPIP39 or TbPTP1, or the two
phosphatases in combination (Supplemental Fig. 3A,B,
columns 5–8). This demonstrated that both metabolites
produced a concentration-dependent reduction of the
enhanced phosphatase activity of TbPTP1/TbPIP39 when
combined. Eliminating the possibility that divalent cat-
ion chelation was responsible for this, citrate or cis-
aconitate had no effect on either TbPIP39 or TbPTP1 alone
(Supplemental Fig. 3A,B, columns 1–4,9–12).
Combined, these experiments demonstrated that
TbPIP39 showed less activity when nonphosphorylated;
i.e., as the product of TbPTP1 activity, whereas TbPIP39
could activate TbPTP1. Moreover, we found that this
regulatory interaction between TbPTP1 and TbPIP39 was
abolished by citrate and cis-aconitate, both of which act
as trypanosome differentiation stimuli.
Life cycle regulation and glycosomal location
of TbPIP39
TbPTP1 acts in stumpy forms to prevent the parasites
undergoing spontaneous differentiation to procyclic forms
(Szo¨}or et al. 2006). To investigate whether its substrate,
TbPIP39, was present at the same life cycle stage, the
RNA and protein expression of TbPIP39 was investigated
in bloodstream slender, bloodstream stumpy, and cultured
procyclic forms of T. brucei. Although the mRNA for
TbPIP39 was abundant in all life cycle stages (albeit
enriched in bloodstream stumpy forms) (Fig. 3A), TbPIP39
protein was barely detectable in slender forms, but was
expressed in stumpy and elevated during differentiation
and in procyclic forms (Fig. 3B; Supplemental Fig. 4A),
demonstrating regulation at the level of protein synthesis
or turnover. Interestingly, the migration of the TbPIP39
protein was altered between stumpy and procyclic forms
(Fig. 3B), there being a slightly higher-molecular-weight
form in the latter. This was expected to represent the
phosphorylated form ofTbPIP39. To establish the tyrosine
phosphorylation status of TbPIP39 during differentiation,
Figure 3. TbPIP39 is a procyclic-enriched
glycosomal phosphoprotein. (A) Northern
blot of TbPIP39 expression in bloodstream
slender (Sl), bloodstream stumpy (St), or
cultured procyclic (Pro) forms. The bot-
tom panel shows the ethidium bromide-
stained rRNA, indicating loading. (B)
Western blot of TbPIP39 in bloodstream
slender (Sl), bloodstream stumpy (St), or
cultured procyclic (Pro) forms. In stumpy
forms, a lower-molecular-weight form is
observed, whereas in procyclic forms, a
higher-molecular-weight form predomi-
nates (arrowheads). The constitutively
expressed protein TbZFP3 (Paterou et al.
2006) is included as a loading control.
An empty intervening lane between the
stumpy and procyclic form samples has
been removed for clarity. (C) Digitonin
fractionation of procyclic and stumpy
form cells reacted with an antibody specific for TbPIP39, TbPIP39 (phospho-Y278), a glycosomal protein (aldolase), or a cytosolic
protein (cytosolic PGK). Exposures have been adjusted to best reveal the distribution between fractions for each protein and are not
equivalent between the distinct profiles. In each case, the digitonin concentration is shown with the cell extract being separated into
either soluble or pelleted (organellar) fractions. TbPIP39 cofractionates with glycosomal aldolase. A quantitative analysis of the
fractionation of procyclic forms is shown in Supplemental Figure 6. (D) Localization of TbPIP39 (red) with an N-terminal GFP fusion of
the glycosomal protein TbPEX13 (green). The two proteins colocalize precisely. DNA of the cells was counterstained using DAPI (blue).
Bar, 5 mm.
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an anti-peptide tyrosine phospho-specific antibody di-
rected to Y278 of TbPIP39 (ELD HWR TDE Y*TK C)
was generated. This revealed enhanced phosphorylation
of TbPIP39 within 120 min of exposure to cis-aconitate or
the tyrosine phosphatase inhibitor BZ3 (Supplemental Fig.
4B). Moreover, reactivity of the phospho-specific antibody
was lost upon treatment of procyclic cell extracts with
TbPTP1 (Supplemental Fig. 5B C), establishing Y278 as
the tyrosine phosphorylation site of TbPIP39 in vivo and
the target of TbPTP1. The expression of TbPIP39 was also
elevated in stumpy forms exposed to 20°C (Supplemental
Fig. 4C)—conditions that sensitize trypanosomes to the
differentiation stimuli CCA (Engstler and Boshart 2004),
and elevate the expression and surface distribution of
PAD2, one member of the protein family responsible for
conveying the CCA differentiation signal (Dean et al.
2009). Hence, the developmental expression, thermal reg-
ulation, and predicted phosphorylation profile of TbPIP39
matched expectations for a TbPTP1 substrate involved in
the differentiation control pathway.
When the cellular location of TbPIP39 was investigated
by immunofluorescence, a punctate staining was de-
tected, similar to that of trypanosome glycosomal pro-
teins. This was supported by the analysis of the TbPIP39
protein sequence, which exhibited a predicted C-terminal
peroxisomal location signal (PTS1) (SRL) (Supplemental
Fig. 1A; Opperdoes and Szikora 2006), and the detection
of TbPIP39 in purified procyclic form glycosomes by
proteomic analysis (Colasante et al. 2006). Nonetheless,
to verify thatTbPIP39 associated with the glycosomes, we
assessed the fractionation of the protein under a digitonin
detergent titration. This demonstrated that TbPIP39
cofractionated with a glycosomal marker protein (aldol-
ase) in both procyclic and stumpy forms, this profile being
shared with the phosphorylated form of TbPIP39 detected
using the Y278 phospho-specific antibody (Fig. 3C; Sup-
plemental Fig. 6B). Confirming its association with gly-
cosomes, TbPIP39 colocalized with GFP in a transgenic
procyclic line expressing an N-terminal GFP fusion of
TbPEX13, a glycosomal import protein (Fig. 3D; Verplaetse
et al. 2009; the plasmid was a kind gift of P. Michels,
Brussels). Hence, by sequence prediction, biochemical and
cellular fractionation, and colocalization studies, TbPIP39
was identified as a glycosome-associated protein.
TbPIP39 RNAi inhibits differentiation
of bloodstream forms
To investigate whether TbPIP39 was a component of the
differentiation signaling pathway, its mRNAwas ablated
by tetracycline-regulated RNAi. To assay early differen-
tiation events in a biologically relevant context, it was
important to assay stumpy cells capable of synchronous
differentiation to procyclic forms. Thus, the T. brucei
AnTat1.1 90:13 pleomorphic line was transfected with
the stem–loop RNAi vector pALC14 containing opposing
fragments of the TbPIP39 gene. A transfectant line was
then grown for 6 d in mice provided either without
(DOX) or with (+DOX) 200 mg/mL doxycyline in their
drinking water to induce transcript ablation, and hence
prevent TbPIP39 protein expression in developing
stumpy forms. Although TbPIP39 was ;85% depleted
in the +DOX parasites (Fig. 4A), no reproducible differ-
ence between the progression of the parasitaemia for the
uninduced (DOX) or induced (+DOX) parasites was
observed; moreover, both samples generated highly
enriched stumpy form populations within 6 d (Supple-
mental Fig. 7). This demonstrated that TbPIP39 was not
required for stumpy formation or viability. The stumpy
forms were then harvested and incubated for 16 h at
either 37°C or 20°C, the latter sensitizing the parasites to
physiological levels of CCA (i.e., ;0.1 mM) (Engstler and
Boshart 2004; Dean et al. 2009). Both the +DOX and
DOX populations were then exposed to 0 mM, 0.1 mM,
or 6 mM cis-aconitate in vitro and assayed for their
expression of the differentiation marker EP procyclin
after 4 and 24 h to detect effects on the initiation of
Figure 4. TbPIP39 depletion in stumpy forms inhibits differ-
entiation. (A) Western blots of TbPIP39 from samples derived
from TbPIP39-RNAi cells either induced (+Dox) or uninduced
(Dox) with doxycycline. Samples were incubated overnight at
20°C, and then proteins were isolated 0 h, 4 h, or 24 h after
exposure to 0 mM, 0.1 mM, or 6 mM cis-aconitate. The bottom
panels represent analysis of the same samples using an antibody
against a-tubulin as a loading control. (B) Flow cytometry traces
of EP procyclin expression in four independent stumpy cell
populations either induced (+Dox, orange and green traces) or
not (Dox, blue and red traces) to ablate TbPIP39 by RNAi.
Individual stumpy cell samples were derived from day 6 in-
fections of mice either with or without doxycyline in their
drinking water. Samples were incubated at 20°C before the ad-
dition of cis-aconitate, and flow cytometry was carried out
either 4 h or 24 h later. The induced populations showed re-
duced differentiation at 0.1 mM (4 h and 24 h); at 6 mM,
differentiation was efficient in all populations (likely enabled by
the remaining ;15% TbPIP39 in the RNAi line), although it
was delayed in the induced samples. Flow cytometry traces
from this experiment with cells incubated at 37°C are available
in Supplemental Figure 8.
Szo¨}or et al.
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differentiation. Although the extent of TbPIP39 depletion
and the overall kinetics of EP procyclin expression in
different experiments varied, perhaps reflecting the
amount of remaining enzyme following RNAi (;15%),
the TbPIP39-depleted parasites showed reduced differen-
tiation with 0.1 mM cis-aconitate (mean, 58% reduction;
range, 52%–67% reduction at 24 h) (Fig. 4B), this effect
being consistent in five out of five experiments, whereas
at 6 mM cis-aconitate, an effect of TbPIP39 depletion was
observed in only two out of five experiments. Hence, the
depletion of TbPIP39 reduced the differentiation of
stumpy forms, with a reduction of sensitivity to physio-
logical levels of CCA. Being detected in uniform popula-
tions of cells before the onset of outgrowth as procyclic
forms, we conclude that TbPIP39 acts as a positive signal-
ing component operating downstream from, and nega-
tively regulated by, TbPTP1.
To confirm that the differentiation signaling response
required the glycosomal location of TbPIP39, we inves-
tigated the ability of mutants with a deleted or an epi-
tope tag-blocked C-terminal PTS1 signal to rescue the
TbPIP39 RNAi-mediated differentiation phenotype. To
achieve this, monomorphic bloodstream forms capable of
TbPIP39 RNAi (Supplemental Fig. 9) were engineered to
express recoded synthetic genes that would be immune to
RNAi, but encode proteins of the same amino sequence
as endogenous TbPIP39 (Supplemental Fig. 10A,B). Ini-
tially, the monomorphic TbPIP39 RNAi line was stimu-
lated to differentiate with cis-aconitate, demonstrating
reduced procyclin expression over 48 h when RNAi was
induced with tetracycline (Fig. 5A). When a wild-type
recoded TbPIP39 copy was coexpressed in the same line,
however, differentiation was fully restored, supporting
rescue of the phenotype (Fig. 5B). In contrast, the expres-
sion of TbPIP39DSRL or TbPIP39-C terminal Ty, both
of which were cytosolic by digitonin fractionation (Sup-
plemental Fig. 10C), failed to rescue the differentiation
phenotype (Fig. 5C,D), as did a catalytically inactive
(TbPIP39dEdE) TbPIP39 mutant (Fig. 5E). These observa-
tions support the glycosomal location and activity of
TbPIP39 being important for differentiation signaling.
Discussion
We demonstrated previously that the tyrosine phospha-
tase TbPTP1 acts as a ‘‘molecular brake’’ that prevents
differentiation of bloodstreams stumpy forms in the
mammalian bloodstream (Szo¨}or et al. 2006). In this study,
we identify a downstream substrate of TbPTP1 as a sec-
ond phosphatase, TbPIP39. TbPIP39 is shown to be a
developmentally regulated magnesium-dependent phos-
phatase whose activity is modulated by tyrosine phos-
phorylation. Moreover, we show that TbPIP39 contrib-
utes to the efficient differentiation to procyclic forms,
thereby invoking the existence of a phosphatase signaling
cascade regulating trypanosome development. Support-
ing this, we show regulatory cross-talk between TbPIP39
and TbPTP1 in vitro, this being abolished by the differ-
entiation regulators citrate and cis-aconitate. Finally, we
demonstrate that TbPIP39 is glycosomal, identifying this
molecule as a newmarker for distinguishing bloodstream
from procyclic form glycosomes, and the first example of
a signaling molecule targeted to this fundamental meta-
bolic organelle in trypanosomes. To our knowledge, this
is the first well-characterized signaling pathway targeted
directly to a peroxisomal-type organelle in any eukaryotic
cell.
TbPIP39 was identified as an unusual type of Ser/Thr
phosphatase, a DxDxT phosphatase. This is an emerging
family of phosphatases, and one of a group of such phos-
phatases encoded in kinetoplastid genomes (14, 13, and 13
members, in T.brucei, T.cruzi, and L. major, respectively)
Figure 5. An intact glycosomal targeting signal is required for
TbPIP39-dependent differentiation. (A) T. brucei single-marker
bloodstream forms were transfected with the TbPIP39 RNAi
construct used in Figure 4. The resulting transfectant cell line
was then induced (blue) or not induced (red) to ablate TbPIP39
by incubation with 1 mg/mL tetracycline for 2 d. The RNAi-
depleted cells and the uninduced controls were then stimulated
to differentiate to procyclic forms by the addition of 6 mM cis-
aconitate and the expression of the differentiation marker EP
procyclin monitored by flow cytometry. Depletion of TbPIP39
resulted in reduced differentiation efficiency at 48 h after ex-
posure to cis-aconitate. (B) The same cell line as in A was
transfected with pHD451 expressing an intact recoded synthetic
TbPIP39 gene, expressed under tetracycline regulation. Cells
were grown with tetracycline for 2 d, allowing silencing of the
endogenous TbPIP39 transcript and expression of the recoded
gene. Differentiation was then monitored for EP procyclin ex-
pression 48 h after exposure to 6 mM cis-aconitate using flow
cytometry. The differentiation phenotype was fully rescued. (C)
As in B, but the recoded synthetic gene product lacked the DSRL
glycosomal targeting signal and redistributed to the cytosolic
fraction (Supplemental Fig. 10C). In this case, the differentiation
defect was not rescued. (D) As in B, but the recoded synthetic
gene product contained a Ty1 epitope tag after the DSRL
glycosomal targeting signal. As with the truncated mutant,
the protein was redistributed to the cytosolic fraction (Supple-
mental Fig. 10C) and the differentiation defect was not rescued.
(E) As in B, but the recoded synthetic gene product was mutated
for the DxDxT motif (to ExExT) to prevent catalytic activity. No
rescue of the differentiation defect was observed.
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(Brenchley et al. 2007), but the only representative pos-
sessing a predicted PTS1. Consistent with expectations
for this class of molecules (Selengut and Levine 2000;
Ndubuisil et al. 2002), TbPIP39 showed magnesium-
dependent activity, with its activity being abolished by
mutation of the predicted magnesium-coordinating as-
partate residues in the DxDxT phosphoryl acceptor motif
(Collet et al. 1998). Interestingly, however, when TbPIP39
was coincubated with TbPTP1, the overall phosphatase
activity of the combined enzymes was elevated over their
predicted additive values. Since the effect was observed
with inactive TbPIP39 (i.e., in the absence of magnesium)
and was not recapitulated when TbPIP39 was incubated
with a catalytically dead C229S mutant of TbPTP1, we
assign the enhanced phosphatase activity of TbPTP1/
TbPIP39 to an activation of TbPTP1. While being poten-
tially muted by the relatively high levels of citrate in the
Escherichia coli expression system (;5 mM), we ob-
served that the activation of recombinant TbPTP1 re-
quired a 10-fold excess of its substrate, TbPIP39, in vitro.
In vivo, the physiological interactions between the pro-
teins could be enhanced significantly by their relative
context or the presence of associated proteins in the cell,
but nonetheless TbPIP39 is in considerable excess of
TbPTP1 in stumpy forms (Supplemental Fig. 4D). Hence,
TbPIP39 is predicted to promote its own dephosphoryla-
tion by activating TbPTP1. Given our finding that the
Y278-phosphorylated form of TbPIP39 shows greater
phosphatase activity than its unphosphorylated form,
these observations combine to generate a feedback loop
whereby TbPIP39 reinforces its own dephosphorylation,
and hence repression, by activating TbPTP1.
Although TbPTP1 was found to be a cytosolic/
cytoskeletally associated protein (Szo¨}or et al. 2006), its
substrate, TbPIP39, was found to be glycosomally asso-
ciated. This apparent paradox can be resolved by consid-
ering the maturation of proteins as they are trafficked to
peroxisome-related organelles, such as glycosomes. Such
proteins are initially translated in the cytosol and then
folded. The peroxisomal targeting signal is then recog-
nized, and the protein is translocated to the peroxisome
membrane where it is imported via peroxins to the
lumen. This passage through the cytosol, from synthesis
to import, has been measured to take from 5 to 60 min
(McNew and Goodman 1994; Terlecky et al. 2001), pro-
viding ample opportunity for TbPIP39 to be phosphory-
lated or dephosphorylated prior to glycosome targeting.
Based on our experiments, we propose a new model for
the early steps in trypanosome differentiation (Fig. 6). In
stumpy forms, TbPIP39 would be synthesized, but held
relatively inactive through its dephosphorylation by
TbPTP1, this being reinforced by the enhanced activity
of TbPTP1 generated by its substrate when in excess.
When trafficked to the glycosome, dephosphorylated,
inactive TbPIP39 would not stimulate differentiation.
When entering the tsetse, however, temperature reduc-
tion to 20°C would facilitate CCA transport into the cell
via PAD expression (Dean et al. 2009). If matching our
in vitro observations, this would prevent the feedback
activation of TbPTP1 by TbPIP39, although CCA may
also inhibit TbPTP1 indirectly through other unknown
mechanisms. Combined with the enhanced expression of
TbPIP39 at low temperature, this would increase the
level of phosphorylated TbPIP39, which, upon entry to
the glycosome, would promote differentiation.
The proposed pathway is reminiscent of cell fate de-
cision pathways in other eukaryotes, whereby phosphor-
ylation–dephosphorylation events coordinate a transition
from one stable state to another—a so-called bistable
switch (Pomerening et al. 2003; Ingolia andMurray 2007).
In this case, the activation of TbPTP1 by TbPIP39 would
repress differentiation by enhancing the dephosphoryla-
tion of TbPIP39, whereas exposure to CCA would allevi-
ate this repression, favor TbPIP39 phosphorylation, and
so stimulate differentiation. Importantly, the sequestra-
tion of phosphorylated TbPIP39 in the glycosomal com-
partment would protect it from further TbPTP1 activity,
rendering its activation irreversible. Although metabolic
regulation via phosphorylation represents an obvious
point of downstream control (Christofk et al. 2008) and
is a known regulator of differentiation events (Milne et al.
1998; Morris et al. 2002), glycosomes are predicted to
comprise >200 distinct proteins (Colasante et al. 2006;
Opperdoes and Szikora 2006) associated with ether lipid
biosynthesis, the b oxidation of fatty acids, purine sal-
vage, pyrimidine biosynthesis, gluconeogenesis, and iso-
prenoid biosynthesis, in addition to glycolysis. Several
identified DxDxT phosphatases, including Dullard, a reg-
ulator of mammalian nuclear membrane biogenesis,
exhibit lipid phosphatase activity (Kim et al. 2007; Reddy
et al. 2008), suggesting that these enzymes may have the
potential to regulate second messenger signaling path-
ways. Hence, any one, or several, of the trypanosome
Figure 6. A model depicting the regulatory interactions be-
tween TbPTP1 and TbPIP39 when exposed to the differentiation
triggers citrate or cis-aconitate. The CCA signal is conveyed by
PAD proteins expressed on the surface of stumpy forms. This
inhibits the activation of TbPTP1 by TbPIP39, although
TbPTP1 may also be inactivated indirectly. Upon the inactiva-
tion of TbPTP1, phosphorylated TbPIP39 predominates, this
being generated by an unidentified protein kinase. TbPIP39,
activated by phosphorylation, is directed toward the glycosomes
by its C-terminal PTS1 signal, and therein promotes a differen-
tiation response.
Szo¨}or et al.
1312 GENES & DEVELOPMENT
glycosomal activities may be regulated by TbPIP39 with
consequences independent of, or indirectly linked to
(Chambers et al. 2008), metabolism.
The existence of signaling pathways directed to perox-
isome-like organelles, and specifically glycosomes, has
been proposed previously (Albert et al. 2005; Michels and
Rigden 2006). Our experiments establish that such a path-
way exists, comprising a phosphatase signaling cascade
that drives an early step in cell type differentiation in
African trypanosomes. Moreover, the bistable regulation
of this pathway by the physiological conditions encoun-
tered during stumpy form transmission suggests a new
elegance to trypanosome developmental control, linked
to the biology of their key metabolic organelle, the
glycosome.
Materials and methods
Parasite growth and transfection
Bloodstream form and procyclic form trypanosomes were cul-
tured in vitro in HMI-9 medium (Hirumi and Hirumi 1984) or
SDM-79 medium (Brun and Schonenberger 1979), respectively.
Culturing, differentiation, pleomorphic trasnfection, and cold-
shock assays of parasites were performed as described in Dean
et al. (2009) using the T. brucei AnTat1.1 90:13 cell line (Engstler
and Boshart 2004), transfectants being generated using an
AMAXA nucleofector protocol (T-cell nucleofection buffer, pro-
gram X001) and selected using 0.5 mgmL1 puromycin. Stumpy-
enriched populations were obtained by DEAE cellulose purifi-
cation (Lanham 1968) of parasites 6–7 d after infection into
cyclophosphamide-treated mice.
For ectopic expression, T. brucei Lister 427 bloodstream forms
were used, these being engineered previously to express the
tetracycline repressor protein (Wirtz et al. 1999), enabling reg-
ulated gene expression of wild-type or substrate-trapping forms
of TbPTP1 (Szo¨}or et al. 2006). Established, cultured procyclic
forms were T. brucei Lister 427.
A transgenic procyclic line expressing an N-terminal GFP
fusion of PEX13, a glycosomal import protein, was created by
transfection of a previously characterized expression plasmid
kindly provided by Paul Michels (Universite´ Catholique de
Louvain, Brussels) (Verplaetse et al. 2009).
DNA cloning
The TbPIP39 coding region was amplified using TbPIP39-specific
primers Primer 1 (see Table 1) and Primer 2, and was integrated
into the pGEX4T1 (GE Heathcare Lifesciences) protein expres-
sion vector for recombinant protein production. Primer 3 and
Primer 4 (see Table 1) were used to insert TbPIP39 into the
pHD451 trypanosome ectopic expression vector (Biebinger et al.
1997). The pGEX4T1TbPIP39 construct was used as a template
for site-directed mutagenesis in order to mutate TbPIP39 Tyr
278 to phenylalanine (abbreviated Y278F TbPIP39). This was
carried out using a commercial site-directed mutagenesis kit
(Stratagene) using the mutagenesis primers Primer 5 and Primer
6 (see Table 1). Recoded synthetic genes (Supplemental Fig. 10)
were synthesized by Geneart (http://www.geneart.com), re-
cloned into pHD451, and transfected into monomorphic cells
already containing the pALC14TbPIP39 RNAi plasmid as a sta-
ble integrant.
Generation of TbPIP39 RNAi cell line
The TbPIP39 reading frame was amplified from genomic DNA
by PCR using Primer 7 and Primer 8 (Table 1), and was integrated
into the HindIII–XbaI and XhoI–NdeI cloning sites of pALC14
(Pusnik et al. 2007) to generate the pALC14TbPIP39 RNAi
plasmid.
Antibody production
Polyclonal antibody was produced in rabbits against full-length
recombinant TbPIP39 by Eurogentec; an anti-peptide phospho-
278YTbPIP39 antibody was raised in rabbits against the se-
quence N-ELDHWRTDE-[phospho]Y-TKC-C from the amino
acid sequence at position 269–281 in TbPIP39 (Eurogentec).
The resulting antibody was affinity-purified against the phos-
phorylated peptide immunogen, andwas counterselected against
the nonphosphorylated peptide to maximize specificity.
Substrate trapping with TbPTP1D199A
The production and purification of the substrate-trapping mu-
tant of TbPTP1 (TbPTP1D199A) was described in Szoor et al.
(2006). Purified His-TbPTP1D199A was mixed with His chelat-
ing Ni-NTA Agarose beads (Qiagen) for 30 min at 4°C. The beads
were then collected by centrifugation and washed three times
with ice-cold His purification lysis buffer (20 mM Tris, 250 mM
NaCl, 1% Triton-X, 1 mM b mercaptoethanol, 5 mM Imidazole
at pH 7.5–8) supplemented with complete, and EDTA-free pro-
tease inhibitor cocktail (Roche).
Approximately 5 3 108 DEAE-purified T. brucei stumpy cells
were harvested by centrifugation, and the cell pellet was frozen
in liquid nitrogen. Cells were then lysed in the presence of
150 mM PTP1B inhibitor BZ3 (Calbiochem) by addition of
500 mL of His purification lysis buffer supplemented with com-
plete, and EDTA-free protease inhibitor cocktail (Roche). The
extract was lysed by two freeze/thaw cycles at80°C, centrifuged
for 20 min at 4°C in a microfuge, and then sonicated for 3 min in
a water bath. Quantification of cellular protein was performed by
the Bradford method following the manufacturer’s instructions.
Table 1. Oligonucleotides used in the study
Oligonucleotide name Sequence
Primer 1 (BamHI Fwd) 59-TATGGATCCATGGTGAGGACGACACGCTTTTC-39
Primer 2 (XhoI Rev) 59-ATACTCGAGCTAAAGTCTTGAAGGAGTGTGTC-39
Primer 3 (HindIII Fwd) 59-TATAAGCTTATGGTGAGGACACGCTTTTC-39
Primer 4 (BamHI Rev) 59-ATAGGATCCCTAAAGTCTTGAAGGAGTGTGTC-39
Primer 5 (Y278F Fwd) 59-CCATTGGCGTACGGATGAGTTCACAAAGTGTGACGACTTTCG-39
Primer 6 (Y278F Rev) 59-CGAAAGTCGTCACACTTTGTGAACTCATCCGTACGCCAATGG-39
Primer 7 (HindIIIBamHIFwd) 59-ATAAAGCTTGGATCCGTGAGGACGACACGCTTTTCACG-39
Primer 8 (XhoINdeI Rev) 59-TGCCATATGCTCGAGGGGAGTTGTAACACCTGCACCTCC-39
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Approximately 0.5 mg of fresh cell extract was incubated for
1.5 h on ice with 20–30 mL of Ni-NTA beads coated with His-
tagged protein; nonspecific interactions were removed by wash-
ing the beads three times with 1 mL of 20 mM Tris, 250 mM
NaCl, and 20 mM imidazole (pH: 8.0), and the bound proteins
were eluted by addition of SDS-PAGE sample buffer.
Mass spectrometry
Eluate from substrate-trapping columns was separated by SDS-
PAGE, and Coomassie Blue-stained bands were excised and
washed in 100 mM ammonium bicarbonate with shaking for
1 h at room temperature, followed by a second wash in 50%
acetonitrile/100 mM ammonium bicarbonate. Proteins were
reduced with 3 mM DTT in 100 mM ammonium bicarbonate
for 30 min at 60°C, followed by alkylation with 10 mM
iodoacetamide for 30 min in the dark at room temperature.
The gel pieces were washed with 50% acetonitrile/100 mM
ammonium bicarbonate, shaking for 1 h at room temperature,
and then were dehydrated by incubation with 0.1 mL of ace-
tonitrile for 10 min at room temperature. All liquid was removed
and gel pieces were dried to completion under vacuum, then
rehydrated with a sufficient volume of trypsin (Promega se-
quencing grade, 2 mg/mL in 25 mM ammonium bicarbonate) to
cover the gel pieces. Digestion was performed overnight at 37°C,
the gel pieces washed for 10min with 0.02mL of 1% formic acid,
and then 0.02 mL acetonitrile was added. After 10 min of in-
cubation, all liquid was transferred to a fresh tube, and the tryp-
tic peptides were dried to completion.
Tryptic peptides were solubilized in 0.5% formic acid and 2%
acetonitrile, and were fractionated on a nanoflow HPLC system
(Famos/Switchos/Ultimate, LC Packings) before being analyzed
by electrospray ionization (ESI) mass spectrometry on a Q-STAR
Pulsar i hybrid MS/MS System. Peptide separation was per-
formed on a Pepmap C18 reversed-phase column (LC Packings)
using a 5%–85% v/v acetonitrile gradient (in 0.5% v/v formic
acid) run over 45min. The flow rate wasmaintained at 0.2 mL per
minute.Mass spectrometric analysis was performed using a 3-sec
survey MS scan, followed by up to four MS/MS analyses of
the most abundant peptides (3 sec per peak) in Information-
Dependent Acquisition (IDA)mode, choosing 2+ to 4+ ions above
threshold of 30 counts, with dynamic exclusion for 120 sec.
Mass spectrometry data was analyzed using Applied Biosys-
tems Analyst QS (version 1.1) software and the automated
Matrix Science Mascot Daemon server (version 2.1.06). Protein
identifications were assigned using the Mascot search engine,
with carbamidomethylation of cysteines and variable methio-
nine oxidation being allowed. An MS tolerance of 1.2 Da for MS
and 0.4 Da for MS/MS analysis was used. Searches were
performed against the T. brucei genome database (version 3) ob-
tained from theWellcome Trust Sanger Institute andmaintained
on a local Mascot server.
Digitonin permeabilization assay
Approximately 5 3 108 procyclic forms were collected to per-
form digitonin permeabilization. The cell suspension was di-
luted to ;1 mg of total protein per milliliter, and increasing
amounts of digitonin (0.01–5 mg/mg total protein) were used in
digitonin assays according to Ferella et al. (2008).
Immunoprecipitation
Transgenic bloodstream form cell lines in which either wild-type
TbPTP1 or TbPTP1-D199A proteins were expressed ectopically
with a C-terminal Ty1 epitope tag sequence (Szo¨}or et al. 2006)
were treated with 6 mM cis-aconitate for 24 h. Immunoprecip-
itation was carried out using 13 108 to 53 108 cells as described
in Paterou et al. (2006).
Western and Northern blotting
Western blotting and Northern blotting was performed as de-
scribed in Tasker et al. (2000). For Western blotting, primary
antibodies were diluted 1:1000 and secondary antibodies were
diluted 1:5000. Proteins were detected using the LI-COR Odys-
sey system for quantification against a tubulin or loading con-
trol as described in Dean et al. (2009). For Northern blots, a
digoxygenin-labeled TbPIP39-specific riboprobe (Roche) was
used, hybridization being detected using CDP-star as a reaction
substrate.
Phosphatase and kinase activity assays
Phosphatase activity was measured by monitoring the TbPIP39-
catalyzed and TbPTP1-catalyzed (0.01–1 mg) hydrolysis of pNPP
to p-nitrophenol (Szo¨}or et al. 2006). Phosphorylation of recombi-
nant TbPIP39 by FGR kinase was performed according to the
manufacturer’s instructions (Calbiochem). The reaction, con-
taining purified TbPIP39 (5 mg), was initiated with the addition of
FGR kinase, and samples were taken at time points after in-
cubation (0, 30, 60, 90, 120, 240 min) at 30°C for Western blots.
After the 240-min time point, the remainder of the phosphory-
lation mixture was loaded on a GSTrap HP column (GE Health-
care Life Sciences) to remove the GST-tagged FGR kinase. After
collection of the flow-through from the column containing the
phosphorylated TbPIP39, the sample was concentrated on Viva-
spin 2 columns with a 10-kDa-molecular-weight cutoff (Sarto-
rius AG) before use in the in vitro TbPTP1 phosphatase assay.
In vitro TbPTP1 phosphatase assay
Tomonitor phosphatase activity of phosphorylated TbPIP39, the
concentrated phosphorylated TbPIP39 was treated with either
1 mg of active wild-type TbPTP1 or the same amount of inactive
C229S TbPTP1 mutant in a 100-mL phosphatase assay (50 mM
Tris, 50 mM Bis Tris, 100 mMNa acetate, 1mM DTTat pH 5.5).
The phosphatase reaction was started with the addition of
TbPTP1, and, after 30 min of incubation at 37°C, 20-mL samples
were removed for Western blot.
Flow cytometry and immunofluorescence
Differentiating cells (23 106 to 53 106) were harvested and fixed
in 2% formaldehyde/0.05% glutaraldehyde for a minimum of 1 h
at 4°C. Antibody staining was executed according to Dean et al.
(2009). Flow cytometry analysis was performed using the BD
LSRII Flow cytometer (Becton Dickenson), and flow cytometry
data was analyzed using FlowJO 8.8.6 software (Tree Star, Inc.)
with unstained cells; cells stained with only the secondary
antibody provided negative controls. For immunofluorescence,
air-dried smears of parasites were prepared and fixed inmethanol
for at least 30 min at 20°C. Cells were rehydrated in PBS for
30 min before labeling, as described in Dean et al. (2009).
Image acquisition equipment and settings
Phase-contrast and immunofluorescence microscopy images
(Supplemental Fig. 7A) were captured on a Zeiss Axioskop2 (Carl
Zeiss Microimaging) with a Prior Lumen 200 light source using
a QImaging Retiga 2000RCCD camera; objectives were either
Plan Neofluar 363 (1.25 NA) or Plan Neofluar 3100 (1.30 NA).
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Images were captured via QImage (QImaging). Confocal imaging
(Fig. 3D) used a Leica SP5 confocal laser scanning microscope,
using 363 oil immersion objective (NA = 1.4), with 4.2 zoom.
The green channel was imaged using a 488-nm argon laser, and
the red channel was imaged using a 543-nm helium/neon laser.
The final image was acquired using Volocity Software (Improvi-
sion Ltd.) version 4.4.
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